MFS
LGND icon

MSI Financial Services’s Ligand Pharmaceuticals LGND Stock Holding History

MSI Financial Services’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3K Sell
43
-53
-55% -$3.35K ﹤0.01% 3360
2016
Q3 		$6K Hold
96
– – ﹤0.01% 3049
2016
Q2 		$7K Hold
96
– – ﹤0.01% 2963
2016
Q1 		$6K Hold
96
– – ﹤0.01% 3067
2015
Q4 		$7K Buy
+96
New +$5.93K ﹤0.01% 2911

Other funds holding LGND

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MSI Financial Services's LGND Position: Q4 2016 in Review

MSI Financial Services reduced its Ligand Pharmaceuticals (LGND) stake by 55% in Q4 2016, selling an estimated $3.35K and leaving 43 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #3360.

MSI Financial Services first reported a position in LGND in Q4 2015 and has held it in 5 quarters since. The position peaked at $7K in Q2 2016. 270 funds tracked by Wall St. Rank hold LGND as of Q4 2016.

  • MSI Financial Services held 43 shares of Ligand Pharmaceuticals worth $3K as of Q4 2016.
  • MSI Financial Services sold 53 Ligand Pharmaceuticals shares in Q4 2016, an estimated $3.35K.
  • Ligand Pharmaceuticals made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3360 holding.
  • MSI Financial Services first reported a position in Ligand Pharmaceuticals in Q4 2015 and has held it in 5 quarters since.
  • MSI Financial Services's Ligand Pharmaceuticals position peaked at $7K in Q2 2016.
  • 270 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.